$东阳光药(0688_老虎社区_美港股上老虎

$东阳光药(06887)$ 自主研发GLP-1/FGF21双靶点新药签 9.38亿美元海外授权！肺纤维化新药伊非尼酮Ⅲ期临床，克立福替尼联手三生制药，创新管线进入变现期

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":469563626803248,"tweetId":"469563626803248","gmtCreate":1755670693375,"gmtModify":1755670694616,"author":{"id":4111461471939460,"idStr":"4111461471939460","authorId":4111461471939460,"authorIdStr":"4111461471939460","name":"方新侠YY","avatar":"https://static.tigerbbs.com/9c047f61fcd0850109e2b3261bd2ddc4","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":6,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/06887\">$东阳光药(06887)$ </a>自主研发GLP-1/FGF21双靶点新药签 9.38亿美元 海外授权！肺纤维化新药伊非尼酮Ⅲ期临床，克立福替尼联手三生制药，创新管线进入变现期</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/06887\">$东阳光药(06887)$ </a>自主研发GLP-1/FGF21双靶点新药签 9.38亿美元 海外授权！肺纤维化新药伊非尼酮Ⅲ期临床，克立福替尼联手三生制药，创新管线进入变现期</p></body></html>","text":"$东阳光药(06887)$ 自主研发GLP-1/FGF21双靶点新药签 9.38亿美元 海外授权！肺纤维化新药伊非尼酮Ⅲ期临床，克立福替尼联手三生制药，创新管线进入变现期","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/469563626803248","repostId":0,"isVote":1,"tweetType":1,"viewCount":379,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["06887"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":136,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/469563626803248"}